Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RAD51–single-stranded DNA (ssDNA) filament is a specialized nucleoprotein complex that serves as the central catalytic intermediate in homologous recombination (HR), a high-fidelity DNA double-strand break repair pathway [PMID: 29074303]. Formed when DNA repair protein RAD51 monomers polymerize onto 3'-overhangs of resected DNA, this right-handed helical structure facilitates the search for a homologous DNA template and catalyzes strand invasion [PMID: 18541574]. Beyond repair, these filaments play a vital role in stabilizing stalled replication forks, preventing their nucleolytic degradation and ensuring genome integrity during S-phase [PMID: 28445450]. In the context of oncology, RAD51 is frequently overexpressed in various malignancies, where it promotes resistance to DNA-damaging agents like cisplatin and ionizing radiation [PMID: 25616105]. Therapeutic strategies targeting the RAD51-ssDNA filament involve small molecules that either prevent RAD51 assembly onto DNA or disrupt the stability of the pre-formed filament, thereby sensitizing cancer cells to treatment [PMID: 24413439]. Such inhibitors are of particular interest for treating tumors with "BRCAness" or as part of combination therapies to overcome chemoresistance [PMID: 30635554]. The filament's assembly is tightly regulated by mediator proteins like BRCA2, which facilitate the displacement of RPA from ssDNA to allow RAD51 loading [PMID: 20616063]. Disruption of this complex can lead to genomic instability, making it a double-edged sword in both cancer progression and therapy.
Inhibition of RAD51 polymerization onto single-stranded DNA, disruption of the nucleoprotein filament structure, or inhibition of RAD51-associated ATPase activity to prevent strand exchange [PMID: 22147242, 24413439].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA repair protein RAD51–single-stranded DNA filament (RAD51-ssDNA filament).